Patents by Inventor Stephen Monroe

Stephen Monroe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210341131
    Abstract: Electrical lighting housings and heat sinks constructed of pitch-based carbon fiber that act as heat sinks for light emitting diode (“LED”/“LEDs”) lights. Greater heat dissipation cools the LED lights and power suppling components, which in turns increases the life span of these components, without the need for active cooling. Due to the improved physical strength of pitch-based carbon fiber over aluminum and other typical heat sink and housing materials, the wall thickness of a housing can be decreased when using pitch-based carbon fiber which can further aid in thermal transfer.
    Type: Application
    Filed: April 26, 2021
    Publication date: November 4, 2021
    Inventors: Stephen Monroe Plash, IV, Geoffrey William Germon
  • Publication number: 20070298121
    Abstract: A synthesized composition containing zinc ions, calcium ions, rubidium ions and/or potassium ions in a pharmaceutically acceptable carrier, which, when applied to an open wound, effectively modulates the activity of at least MMP-2 and/or MMP-9 in the wound. A method for treatment of wounds is disclosed.
    Type: Application
    Filed: July 17, 2007
    Publication date: December 27, 2007
    Inventors: Stephen Monroe, Matthias Hoekstra
  • Publication number: 20070190178
    Abstract: A synthesized composition containing one or more of zinc ions, calcium-ions, rubidium ions and/or potassium ions in a pharmaceutically acceptable carrier, which, when administered to a patient in need thereof, effectively modulates the activity of at least MMP-2 and/or MMP-9 in the wound. A method is disclosed.
    Type: Application
    Filed: April 5, 2007
    Publication date: August 16, 2007
    Inventors: Stephen Monroe, Hans Hoekstra
  • Publication number: 20070128296
    Abstract: Reactive oxygen species associated with a wound are modulated through treatment of the wound with a solution of metal ions selected from the group consisting of potassium ions, zinc ions, calcium ions and rubidium ions, at a pH of between about 5 and about 7. Preferably, citric acid is employed to adjust the pH of the solution. Application of the extract to a wound exhibiting superoxide anions has been found to be effective in the treatment of these wounds through the reduction of the level of superoxide anions. Moreover, treatment of partial thickness excision wounds as well as contact burn wounds with the present composition has been found to improve epithelialization of these wounds. In addition to the antioxidant activity of the present invention, treatment of the wound employing the present composition produces inhibitory effects on ROS production by human PMNs and on human complement activation, and therefore, is further beneficial in chronic wound management.
    Type: Application
    Filed: January 3, 2007
    Publication date: June 7, 2007
    Inventors: Hans Hoekstra, Stephen Monroe, A.J.J. Van Den Berg
  • Publication number: 20070114790
    Abstract: A retainer assembly that reduces misalignment of a conduit connection to a component. In addition, the assembly keeps the conduit in place on the component enabling the assembler to complete the assembly without having to hold the conduit. The assembly includes a connection block having a U-shaped retainer attached to the connection block. A retainer clip having an opening therein and a locking finger extending into the opening. The locking finger operative to engage a retention member located on the component to hold the connection block and conduit combination with respect to the component after which a fastener is used to secure the connection block and conduit combination to the component.
    Type: Application
    Filed: November 18, 2005
    Publication date: May 24, 2007
    Inventors: Roy Burmeister, Stephen Monroe, Daniel Shelton
  • Publication number: 20070009611
    Abstract: A synthesized composition containing zinc ions, calcium ions, rubidium ions and/or potassium ions in a pharmaceutically acceptable carrier, which, when applied to an open wound, effectively modulates-the activity of at least MMP-2 and/or MMP-9 in the wound. A method for treatment of wounds is disclosed.
    Type: Application
    Filed: September 20, 2006
    Publication date: January 11, 2007
    Inventors: Stephen Monroe, Matthias Hoekstra
  • Publication number: 20060257501
    Abstract: A synthesized composition containing one or more of zinc ions, calcium ions, rubidium ions and/or potassium ions in a pharmaceutically acceptable carrier, which, when administered to a patient in need thereof, effectively modulates the activity of at least MMP-2 and/or MMP-9 in the wound. A method is disclosed.
    Type: Application
    Filed: July 24, 2006
    Publication date: November 16, 2006
    Inventors: Stephen Monroe, Hans Hoekstra
  • Publication number: 20060029682
    Abstract: A synthesized composition containing zinc ions, calcium ions, rubidium ions and/or potassium ions in a pharmaceutically acceptable carrier, which, when applied to an open wound, effectively modulates the activity of at least MMP-2 and/or MMP-9 in the wound. A method for treatment of wounds is disclosed.
    Type: Application
    Filed: March 15, 2005
    Publication date: February 9, 2006
    Inventors: Stephen Monroe, Matthias Hoekstra
  • Publication number: 20050175715
    Abstract: A mechanism is disclosed wherein depolarization of the cells associated with disease states, wherein matrix metalloproteinases are implicated as a contributor to the pathology of the disease state, and the subsequent regulation of certain proteins beneficially aids control of the matrix metalloproteinases. This initiating trigger can ultimately result in the down-regulation or up-regulation of matrix metalloproteinases. An example is given wherein matrix metalloproteinase 2 (MMP 2) is down-regulated.
    Type: Application
    Filed: August 25, 2004
    Publication date: August 11, 2005
    Inventors: Stephen Monroe, Robert Moore
  • Publication number: 20050014838
    Abstract: A method for treating vascular degeneration and stimulating glucose uptake in diabetics including the administration to a patient of a combination of a dilator of striated muscle microvasculature and chemical entity that stimulates the uptake of glucose in striated muscle in a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 29, 2004
    Publication date: January 20, 2005
    Inventors: Stephen Monroe, Robert Moore